Because cell types other than Th17, such as Th22, could also express CCR6, we measured CD3+ CD8− IL-17A+ cells in PBMCs after stimulation by FACS and found no difference in their proportions between SLE patients and normal controls (data not shown). This evidence concerns the gene IL17A and systemic lupus erythematosus.